PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.52 - 1.58
1.19 - 3.37
354.5K / 984.1K (Avg.)
-1.64 | -0.94
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-6.35%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
26.53%
Gross profit growth under 50% of MAXN's 73.39%. Michael Burry would be concerned about a severe competitive disadvantage.
72.87%
EBIT growth similar to MAXN's 71.83%. Walter Schloss might infer both firms share similar operational efficiencies.
78.67%
Operating income growth 1.25-1.5x MAXN's 66.50%. Bruce Berkowitz would see if strategic measures (e.g., cost cutting, product mix) are succeeding.
62.22%
Net income growth at 75-90% of MAXN's 73.10%. Bill Ackman would press for improvements to catch or surpass competitor performance.
62.30%
EPS growth of 62.30% while MAXN is zero. Bruce Berkowitz would see if minimal gains can accelerate over time.
62.30%
Diluted EPS growth at 75-90% of MAXN's 73.09%. Bill Ackman would expect further improvements in net income or share count reduction.
0.12%
Share change of 0.12% while MAXN is at zero. Bruce Berkowitz would see if slight buybacks (or dilution) matter in the bigger picture.
0.34%
Diluted share change of 0.34% while MAXN is zero. Bruce Berkowitz might see a minor difference that could widen over time.
No Data
No Data available this quarter, please select a different quarter.
18.17%
OCF growth under 50% of MAXN's 93.92%. Michael Burry might suspect questionable revenue recognition or rising costs.
72.30%
FCF growth 75-90% of MAXN's 91.23%. Bill Ackman might push for improved capital allocation or operational changes to match the competitor.
68.63%
Positive 10Y revenue/share CAGR while MAXN is negative. John Neff might see a distinct advantage in product or market expansion over the competitor.
54.18%
Positive 5Y CAGR while MAXN is negative. John Neff might see an underappreciated edge for the firm vs. the competitor.
46.43%
3Y revenue/share CAGR above 1.5x MAXN's 7.06%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
127.60%
Positive long-term OCF/share growth while MAXN is negative. John Neff would see a structural advantage in sustained cash generation.
259.76%
Positive OCF/share growth while MAXN is negative. John Neff might see a comparative advantage in operational cash viability.
606.49%
Positive 3Y OCF/share CAGR while MAXN is negative. John Neff might see a big short-term edge in operational efficiency.
77.75%
Positive 10Y CAGR while MAXN is negative. John Neff might see a substantial advantage in bottom-line trajectory.
-402.72%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
-448.13%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
No Data
No Data available this quarter, please select a different quarter.
-30.93%
Both show negative equity/share growth mid-term. Martin Whitman suspects cyclical or structural challenges for each company.
-47.25%
Both show negative short-term equity/share CAGR. Martin Whitman suspects an industry slump or unprofitable expansions for both players.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
16.59%
Our AR growth while MAXN is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
-3.44%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
-5.33%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
-5.21%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
-12.86%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
-25.47%
Our R&D shrinks while MAXN invests at 3.39%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
-31.19%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.